Actively Recruiting
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
Led by University Health Network, Toronto · Updated on 2026-03-23
40
Participants Needed
1
Research Sites
416 weeks
Total Duration
On this page
Sponsors
U
University Health Network, Toronto
Lead Sponsor
T
TerSera Therapeutics LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective, randomized phase II trial investigating if radiation treatment delivered every other day for 2 weeks has the same side effects as radiation treatment delivered once weekly for 6 weeks.
CONDITIONS
Official Title
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically-proven prostate cancer
- Presence of low-volume or high-volume metastases (high volume defined as the presence of visceral metastases or 6 bone lesions with at least 1 lesion beyond the vertebral bodies and pelvis)
- Planned to or receiving systemic treatment ADT 1 ARAT as per physician discretion (Previous chemotherapy allowed if completed more than 6 weeks prior to randomization)
- Planned for EBRT
- ECOG performance status 0 or 1
- Age 18 years or older
You will not qualify if you...
- Prior radiotherapy to pelvis
- Active ulcerative colitis or Crohn's Disease, at discretion of treating physician
- Any condition where radiotherapy is contraindicated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9
Actively Recruiting
Research Team
P
Peter Chung, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here